International life science services firm LabCorp is adding a new chief medical officer for across its growing network of operations – and he’s coming from Blue Cross Blue Shield of North Carolina.
Dr. Brian Caveney is taking the newly created CMO position at Burlington-based LabCorp as of Sept. 25. He has worked at BCBS since 2011.
“Brian is a nationally respected thought leader who brings deep expertise to LabCorp on critical topics, including health policy, healthcare financing, regulatory initiatives, value-based care models, and clinical standards of care,” said LabCorp chair and CEO David King.
“Whether in our nation’s capital or at the state level, he is a sought-after voice when health policy is being crafted, and for good reason. In addition to being a highly accomplished managed-care executive, Brian was a practicing physician and holds degrees in medicine, health policy and administration, and law. I can think of no finer choice to become our first enterprise-wide chief medical officer.”
Caveney will oversee LabCorp’s medical and scientific strategy. This will include “serving as primary medical representative for the company externally, defining global standards for medical and scientific activities across LabCorp’s Diagnostics and Drug Development businesses, and enhancing a culture of medical and scientific excellence,” LabCorp said in the announcement..